MX360449B - Vacunas para el virus del papiloma humano y metodos para su uso. - Google Patents
Vacunas para el virus del papiloma humano y metodos para su uso.Info
- Publication number
- MX360449B MX360449B MX2014004537A MX2014004537A MX360449B MX 360449 B MX360449 B MX 360449B MX 2014004537 A MX2014004537 A MX 2014004537A MX 2014004537 A MX2014004537 A MX 2014004537A MX 360449 B MX360449 B MX 360449B
- Authority
- MX
- Mexico
- Prior art keywords
- hpv
- vaccines
- disclosed
- methods
- same
- Prior art date
Links
- 241000701806 Human papillomavirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 101000742671 Human papillomavirus 58 Protein E6 Proteins 0.000 abstract 1
- 241000701828 Human papillomavirus type 11 Species 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229940124590 live attenuated vaccine Drugs 0.000 abstract 1
- 229940023012 live-attenuated vaccine Drugs 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a una molécula de ácido nucleico caracterizada porque comprende una secuencia de nucleótidos que codifica un antígeno de HPV de E6/E7 de fusión de consenso seleccionado del grupo que consiste en: SEQ ID NO: 1, fragmentos que comprenden al menos 786 nucleótidos de la SEQ ID NO: 1 y que tienen al menos 90% de identidad con la SEQ ID NO: 1 y en donde los fragmentos codifican inmunógenos que mejoran respuestas inmunes contra HPV; y combinaciones de éstas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/055932 WO2013055326A2 (en) | 2011-10-12 | 2011-10-12 | Vaccines for human papilloma virus and methods for using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014004537A MX2014004537A (es) | 2014-08-01 |
MX360449B true MX360449B (es) | 2018-11-01 |
Family
ID=48082701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014004537A MX360449B (es) | 2011-10-12 | 2011-10-12 | Vacunas para el virus del papiloma humano y metodos para su uso. |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP3443982A1 (es) |
KR (5) | KR20220035279A (es) |
CN (3) | CN114277038A (es) |
AU (2) | AU2011378812B2 (es) |
CA (2) | CA3161127A1 (es) |
EA (1) | EA033242B1 (es) |
HK (1) | HK1198940A1 (es) |
MX (1) | MX360449B (es) |
WO (1) | WO2013055326A2 (es) |
ZA (1) | ZA201402553B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105307678A (zh) * | 2013-03-12 | 2016-02-03 | 宾夕法尼亚大学理事会 | 用于人乳头状瘤病毒的改进疫苗及其使用方法 |
BR112022007615A2 (pt) * | 2019-10-24 | 2022-07-12 | Univ Pennsylvania | Método para tratar ou prevenir papilomatose respiratória recorrente, e, sequência de nucleotídeo |
CN111647067B (zh) * | 2020-07-02 | 2021-06-04 | 北京广未生物科技有限公司 | AP-2alpha抗体联合用药用于制备治疗宫颈癌的药物中的用途 |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5077044A (en) | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
ZA858044B (en) | 1984-11-01 | 1987-05-27 | American Home Prod | Oral vaccines |
US5643579A (en) | 1984-11-01 | 1997-07-01 | American Home Products Corporation | Oral vaccines |
US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
US5223424A (en) | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
US4790987A (en) | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
US5310668A (en) | 1986-06-20 | 1994-05-10 | Merck & Co., Inc. | Varicella-zoster virus as a live recombinant vaccine |
US5242829A (en) | 1986-09-23 | 1993-09-07 | Therion Biologics Corporation | Recombinant pseudorabies virus |
US5294441A (en) | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
US5387744A (en) | 1987-06-04 | 1995-02-07 | Washington University | Avirulent microbes and uses therefor: Salmonella typhi |
IL86583A0 (en) | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
US5112749A (en) | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
JP3044062B2 (ja) | 1989-03-08 | 2000-05-22 | ヘルス・リサーチ・インク | 組換えポックスウイルス宿主選択系 |
US5225336A (en) | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5591439A (en) | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
AU645489B2 (en) | 1989-03-31 | 1994-01-20 | Washington University | Vaccines containing avirulent phoP-type microorganisms |
EP0431668B1 (en) | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
US5294548A (en) | 1990-04-02 | 1994-03-15 | American Biogenetic Sciences, Inc | Recombianant Hepatitis a virus |
WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
CN1067382A (zh) * | 1990-09-26 | 1992-12-30 | 布里斯托尔-迈尔斯斯奎尔公司 | 人类乳头状瘤病毒肽的表达以及在致免疫组合物中的应用 |
US5462734A (en) | 1990-11-02 | 1995-10-31 | Wisconsin Alumni Research Foundation | Bovine herpesvirus vaccine and method of using same |
US5240703A (en) | 1991-03-01 | 1993-08-31 | Syntro Corporation | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
US6034298A (en) | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US5955088A (en) | 1992-02-03 | 1999-09-21 | Cedars-Sinai Medical Center | Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
US5981505A (en) | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
AU700371B2 (en) | 1993-06-07 | 1999-01-07 | Genentech Inc. | Hiv envelope polypeptides |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
WO1995028942A1 (en) * | 1994-04-26 | 1995-11-02 | Genta Incorporated | Antisense oligomers for inhibiting human papillomaviruses |
US6156319A (en) | 1994-07-25 | 2000-12-05 | The Trustees Of The University Of Pennsylvania | Soluble herpesvirus glycoprotein complex vaccine |
CN1163634A (zh) * | 1994-09-22 | 1997-10-29 | 麦克公司 | 编码6a型人乳头瘤病毒的DNA |
NL9401820A (nl) | 1994-11-02 | 1996-06-03 | Meyn Maschf | Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte. |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5650309A (en) | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
US5698202A (en) | 1995-06-05 | 1997-12-16 | The Wistar Institute Of Anatomy & Biology | Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier |
AUPN443995A0 (en) | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
US6589529B1 (en) | 1998-10-30 | 2003-07-08 | Children's Hospital Medical Center | Rotavirus subunit vaccine |
JP4799789B2 (ja) * | 1999-08-25 | 2011-10-26 | メルク・シャープ・エンド・ドーム・コーポレイション | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 |
US20050100554A1 (en) * | 2002-02-14 | 2005-05-12 | Amanda Jackson | Complexes and methods of using same |
US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
CN1160463C (zh) * | 2002-04-24 | 2004-08-04 | 中国医学科学院肿瘤医院肿瘤研究所 | 人乳头瘤病毒e6/e7融合基因及其高效表达载体和融合蛋白疫苗 |
EP1553966B1 (en) * | 2002-10-03 | 2012-08-01 | Wyeth Holdings Corporation | Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof |
AU2003290460A1 (en) * | 2003-12-24 | 2005-07-14 | Leiden University Medical Center | Synthetic protein as tumor-specific vaccine |
US20080279877A1 (en) * | 2006-02-13 | 2008-11-13 | Fraunhofer U.S.A. Inc. | HPV antigens, vaccine compositions, and related methods |
CN105132439A (zh) * | 2006-07-28 | 2015-12-09 | 宾夕法尼亚大学托管会 | 改进的疫苗及其使用方法 |
PE20081723A1 (es) * | 2007-01-30 | 2008-12-14 | Transgene Sa | Vacuna contra el papilomavirus |
CN101530614A (zh) * | 2008-03-10 | 2009-09-16 | 北京康乐卫士生物技术有限公司 | 五价重组人乳头瘤病毒疫苗 |
CN101530615A (zh) * | 2008-03-10 | 2009-09-16 | 北京康乐卫士生物技术有限公司 | 二价重组人乳头瘤病毒疫苗 |
WO2009128950A2 (en) * | 2008-04-18 | 2009-10-22 | Vaxinnate Corporation | Deletion mutants of flagellin and methods of use |
EA027784B1 (ru) * | 2008-05-26 | 2017-09-29 | Кадила Хелзкэр Лимитед | Комбинированная вакцина против кори и вируса папилломы человека |
CN101280316B (zh) * | 2008-05-26 | 2010-06-09 | 清华大学深圳研究生院 | 人宫颈癌的一种治疗性疫苗 |
CN101591646B (zh) * | 2008-05-27 | 2012-05-30 | 清华大学深圳研究生院 | 一种治疗人宫颈癌的树突状细胞疫苗 |
NZ589755A (en) * | 2008-06-09 | 2013-04-26 | Bharat Biotech Int Ltd | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same |
WO2010054482A1 (en) * | 2008-11-12 | 2010-05-20 | Nventa Biopharmaceuticals Corporation | Immunogenic human papillomavirus compositions |
CA2653478A1 (en) * | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
CN102002105B (zh) * | 2009-09-03 | 2013-01-23 | 中国疾病预防控制中心病毒病预防控制所 | Hpv 16型e7e6融合蛋白基因、表达载体、方法、细胞和用途 |
KR20140137679A (ko) | 2013-05-23 | 2014-12-03 | 삼성전자주식회사 | 카드 소켓 장치 |
-
2011
- 2011-10-12 EP EP18180823.9A patent/EP3443982A1/en active Pending
- 2011-10-12 KR KR1020227007777A patent/KR20220035279A/ko not_active IP Right Cessation
- 2011-10-12 CN CN202111678584.4A patent/CN114277038A/zh active Pending
- 2011-10-12 CN CN201180074173.2A patent/CN103889450B/zh active Active
- 2011-10-12 WO PCT/US2011/055932 patent/WO2013055326A2/en active Application Filing
- 2011-10-12 AU AU2011378812A patent/AU2011378812B2/en active Active
- 2011-10-12 EP EP11873835.0A patent/EP2750703B1/en not_active Not-in-force
- 2011-10-12 KR KR1020197013985A patent/KR102216962B1/ko active IP Right Grant
- 2011-10-12 KR KR1020247016793A patent/KR20240093830A/ko unknown
- 2011-10-12 EA EA201490758A patent/EA033242B1/ru not_active IP Right Cessation
- 2011-10-12 CA CA3161127A patent/CA3161127A1/en active Pending
- 2011-10-12 MX MX2014004537A patent/MX360449B/es active IP Right Grant
- 2011-10-12 CN CN201710995844.8A patent/CN107723299B/zh active Active
- 2011-10-12 KR KR1020217004166A patent/KR102373828B1/ko active IP Right Grant
- 2011-10-12 KR KR1020147012513A patent/KR20140076613A/ko active Application Filing
- 2011-10-12 CA CA2848658A patent/CA2848658C/en active Active
-
2014
- 2014-04-08 ZA ZA2014/02553A patent/ZA201402553B/en unknown
- 2014-12-16 HK HK14112604.7A patent/HK1198940A1/xx unknown
-
2017
- 2017-11-22 AU AU2017265076A patent/AU2017265076B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA3161127A1 (en) | 2013-04-18 |
CA2848658C (en) | 2022-08-02 |
EP3443982A1 (en) | 2019-02-20 |
KR102216962B1 (ko) | 2021-02-18 |
KR20140076613A (ko) | 2014-06-20 |
AU2017265076B2 (en) | 2019-12-05 |
WO2013055326A3 (en) | 2014-04-10 |
CN107723299A (zh) | 2018-02-23 |
EA201490758A1 (ru) | 2014-09-30 |
HK1198940A1 (en) | 2015-06-19 |
WO2013055326A2 (en) | 2013-04-18 |
KR20220035279A (ko) | 2022-03-21 |
CA2848658A1 (en) | 2013-04-18 |
CN107723299B (zh) | 2022-02-01 |
CN103889450B (zh) | 2017-11-21 |
KR20190056450A (ko) | 2019-05-24 |
AU2011378812B2 (en) | 2017-08-24 |
ZA201402553B (en) | 2015-12-23 |
KR20210019133A (ko) | 2021-02-19 |
EA033242B1 (ru) | 2019-09-30 |
MX2014004537A (es) | 2014-08-01 |
CN103889450A (zh) | 2014-06-25 |
AU2017265076A1 (en) | 2017-12-14 |
EP2750703B1 (en) | 2018-07-04 |
AU2011378812A1 (en) | 2014-04-10 |
KR102373828B1 (ko) | 2022-03-14 |
KR20240093830A (ko) | 2024-06-24 |
CN114277038A (zh) | 2022-04-05 |
EP2750703A2 (en) | 2014-07-09 |
EP2750703A4 (en) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
EA201591688A1 (ru) | Усовершенствованные вакцины против вируса папилломы человека и способы их применения | |
MX2013008836A (es) | Moleculas de acido nucleico que codifican novedosos antigenos de herpes, vacunas que las comprenden y metodos para su uso. | |
MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
MX2016011686A (es) | Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc). | |
EA201190327A1 (ru) | Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv | |
EA201591287A1 (ru) | Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения | |
MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
MX358762B (es) | Procesos que utilizan vlps con cápsides resistentes a hidrolasas. | |
NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
PH12014501388A1 (en) | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv | |
MX349657B (es) | Composiciones de vacuna de matriz de proteína que incluyen policationes. | |
EP2589604A4 (en) | SHORTEN L1 PROTEIN OF THE TYPE 52 HUMAN PAPILLOMA VIRUS | |
MA37749B1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
PH12017501100A1 (en) | Recombinant swinepox virus and vaccines | |
MX360449B (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
EP2593548A4 (en) | ANTIGEN E7 COMPOSITIONS OF HUMAN PAPILLOMAVIRUS AND USES THEREOF | |
MX2018013358A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
MX2024007378A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
MX2024007379A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
MX365656B (es) | Nuevas vacunas contra multiples subtipos del virus del dengue. | |
MX2015011064A (es) | Vacuna contra el virus de la leucemia bovina. | |
WO2013093629A3 (en) | Modular vaccines, methods and compositions related thereto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |